ONP-001 (OmniNano Pharmaceuticals)

N/A

Report date: 2025/12/12 17:32:28
NME

Base Information

Drug NameONP-001 (OmniNano Pharmaceuticals)
Drug Alias NamePolymeric micelles co-encapsulating cyclopamine (CPA) and paclitaxel (PTX)ONP-001
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionHedgehog cell-signalling pathway inhibitorsTubulin stabilizers
TargetsTubulin
Therapy Area/IndicationsCarcinoma, HepatocellularCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmniNano Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesOmniNano Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsCarcinoma, HepatocellularCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A